Related Experiment Video
Updated: Aug 8, 2026

Generation and Labeling of Murine Bone Marrow-derived Dendritic Cells with Qdot Nanocrystals for Tracking Studies
Published on: June 2, 2011
Tracking dendritic cells: use of an in situ method to label all blood leukocytes
Bill Ristevski1, Alan J Young, Lisbet Dudler
1Department of Laboratory Medicine and Pathobiology, University of Toronto, 1 Kings' College Circle, Toronto, Ontario M5S 1A8, Canada.
Insights
We developed a novel in situ cell tracking method to monitor dendritic cell (DC) precursors. This technique achieves high labeling efficiency (>98%) for tracking cells from blood to lymphoid tissues.
Area of Science:
- Immunology
- Cell Biology
- Biotechnology
Background:
- Tracking immune cell populations, particularly dendritic cell (DC) precursors, is crucial for understanding immune responses.
- Existing in vitro labeling methods have limitations that can affect cell function and migratory capacity.
Purpose of the Study:
- To develop and validate a novel in situ procedure for high-efficiency labeling and tracking of blood leukocytes, specifically dendritic cell (DC) precursors.
- To enable direct tracking of DC precursors from blood into lymphoid tissues.
Main Methods:
- An in situ procedure was established for labeling blood leukocytes.
- The labeling efficiency was assessed using a labeling index, aiming for >98%.
Main Results:
- The in situ procedure achieved a labeling index exceeding 98% for blood leukocytes.
- This high labeling efficiency allows for direct tracking of dendritic cell (DC) precursors migration.
- Dendritic cells and lymphocytes exhibit comparable migratory capabilities from blood to afferent lymph.
Conclusions:
- The described in situ method provides a robust approach for tracking dendritic cell (DC) precursors and other rare cell populations.
- This technique circumvents the limitations of in vitro labeling, offering broader applications in normal and pathological states.
Abstract:
Here we describe an in situ procedure with a labeling index (percent of labeled blood leukocytes) >98%, which is high enough to permit the direct tracking of dendritic cell (DC) precursors from blood into lymphoid tissues, while circumventing the pitfalls associated with in vitro labeling. DC and lymphocytes have similar blood to afferent lymph migratory capabilities. This method has additional applications in tracking other rare cell populations in both normal and pathological states.
More Related Videos
07:58Quantitative Imaging of Lineage-specific Toll-like Receptor-mediated Signaling in Monocytes and Dendritic Cells from Small Samples of Human Blood
Published on: April 16, 2012
13:10In Situ Detection of Autoreactive CD4 T Cells in Brain and Heart Using Major Histocompatibility Complex Class II Dextramers
Published on: August 1, 2014